Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G03CC06	GYNOFLOR	B	Estriol - 0.03mg, Lactobacillus acidophillus - 10 MIU		Tablet	813,025 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 1,000mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A10BD08	GALVUS MET	B	Metformin HCl - 850mg, Vildagliptin - 50mg		Tablet, film coated	1,816,875 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 15mg/5ml	15mg/5ml	Liquid	258,018 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 50mg	50mg	Tablet	163,949 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml		Drops solution	950,097 L.L
A04AD	GRAVOL	B	Dimenhydrinate - 100mg	100mg	Suppository	294,302 L.L
S01ED51	GANFORT	B	Timolol maleate - 5mg/ml, Bimatoprost - 300mcg/ml		Drops solution	950,097 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 10mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
A10BD19	GLYXAMBI	B	Linagliptin - 5mg, Empagliflozin - 25mg		Tablet, film coated	4,482,387 L.L
J06BA02	GAMUNEX-C	BioHuman	Human normal immunoglobulin G - 10%	10%	Injectable solution	39,990,287 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 900IU/1.5ml	66mcg/1.5ml	Injectable solution	29,625,401 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 450IU/0.75ml	450IU/0.75ml	Injectable solution	14,813,959 L.L
G03GA05	GONAL-f	BioHuman	Follitropin alfa - 300IU/0.5ml	300IU/0.5ml	Injectable solution	10,305,698 L.L
A10AE04	GLARTUS	BioTech	Insulin glargine - 100U/ml	100U/ml	Injectable solution	1,346,530 L.L
H01AC01	GENOTROPIN	BioTech	Somatropin recombinant - 5.3mg/1.15ml	5.3mg/1.15ml	Injectable powder for solution+diluent	4,724,854 L.L
H01AC01	GENOTROPIN GOQUICK	BioTech	Somatropin recombinant - 12mg/ml	12mg/ml	Injectable powder for solution+diluent	25,170,264 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	314,437,416 L.L
L01FA03	GAZYVA	BioTech	Obinutuzumab - 1000mg/40ml	1000mg/40ml	Injectable concentrate for solution	L.L
H04AA01	GLUCAGEN	BioTech	Glucagon HCl - 1mg	1mg	Injectable powder for solution+diluent	1,343,444 L.L
N02BF02	GABRIKA 75	G	Pregabalin - 75mg	75mg	Capsule	793,507 L.L
N02BF02	GALICA 75	G	Pregabalin - 75mg	75mg	Capsule	338,648 L.L
A10BF01	GLUFIX	G	Acarbose - 50mg	50mg	Tablet	1,294,120 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 6g/20ml	30%	Injectable solution	5,157,668 L.L
N02BF02	GABRIKA 100	G	Pregabalin - 100mg	100mg	Capsule	798,626 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	560,062 L.L
L01EA01	GLIMATINIB BENTA 400	G	Imatinib (mesylate) - 400mg	400mg	Tablet, film coated	38,254,090 L.L
N02BF02	GABRIKA 25	G	Pregabalin - 25mg	25mg	Capsule	341,720 L.L